StockData

Cell Source, Inc. (CLCS) stock

CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)

Close on Oct 19, 2026Market cap $21.99MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2025

Valuation

Market cap
$21.99M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
-$4.72M
EPS, diluted
-$0.14
Book value per share
-$0.45
Diluted shares
45M

Trading

Previous close
$0.49
Open
$0.49
Day's range
$0.49 – $0.49
Volume
800
Average volume (20 days)
2,440

Market cap history

Month-end market cap since 2014, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodCLCSS&P 500DifferenceCLCS per yearS&P 500 per year
1 month-2.3%+0.6%−3.0 pts
3 months-43.2%+3.4%−46.6 pts
Year to date-2.3%+13.3%−15.6 pts
1 year+22.1%+16.6%+5.5 pts
3 years-22.5%+86.4%−108.9 pts-8.1%+23.1%
5 years-61.3%+81.9%−143.1 pts-17.3%+12.7%
10 years-43.5%+318.9%−362.4 pts-5.6%+15.4%

Thirteen years at a glance

Fiscal years 2012 to 2024 and trailing twelve months, USD

Revenue

–

Operating income

-$3.70M

Net income

-$4.72M

EPS, diluted

-$0.14

Free cash flow

–
Reported periodTrailing twelve months

About Cell Source

Pharmaceutical Preparations

Cell Source, Inc. is a corporate entity organized under the laws of Nevada. The supplied annual report excerpt consists primarily of regulatory reporting identifiers, financial instruments, and accounting classifications, without disclosing information regarding specific commercial operations, products, services, operating segments, or customers.

Company profile, executives and history

Cell Source stock: common questions

What is Cell Source's stock price?

CLCS closed at $0.49 on Oct 19, 2026, down 0.01% on the day.

What is Cell Source's market cap?

Cell Source was worth $21.99M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is CLCS's P/E ratio?

Cell Source lost money over the twelve months to Mar 31, 2025 (diluted EPS -$0.14), so it has no meaningful P/E ratio.

Does Cell Source pay a dividend?

No. Cell Source has not paid a cash dividend over the last twelve months.

How has CLCS stock performed over the past year?

Including dividends, CLCS returned +22.1% over the past year, against +16.6% for the S&P 500.

Who are Cell Source's competitors?

Companies most similar to Cell Source by business, industry and size include HSTC, PPCB, AKTX, RADX, SNY.

See a number that looks wrong?